634 related articles for article (PubMed ID: 15051755)
1. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.
Roa W; Brasher PM; Bauman G; Anthes M; Bruera E; Chan A; Fisher B; Fulton D; Gulavita S; Hao C; Husain S; Murtha A; Petruk K; Stewart D; Tai P; Urtasun R; Cairncross JG; Forsyth P
J Clin Oncol; 2004 May; 22(9):1583-8. PubMed ID: 15051755
[TBL] [Abstract][Full Text] [Related]
2. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
5. International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.
Roa W; Kepka L; Kumar N; Sinaika V; Matiello J; Lomidze D; Hentati D; Guedes de Castro D; Dyttus-Cebulok K; Drodge S; Ghosh S; Jeremić B; Rosenblatt E; Fidarova E
J Clin Oncol; 2015 Dec; 33(35):4145-50. PubMed ID: 26392096
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial.
Guedes de Castro D; Matiello J; Roa W; Ghosh S; Kepka L; Kumar N; Sinaika V; Lomidze D; Hentati D; Rosenblatt E; Fidarova E
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):931-938. PubMed ID: 28602417
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
8. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
10. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
14. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
16. Radiation response and survival time in patients with glioblastoma multiforme.
Barker FG; Prados MD; Chang SM; Gutin PH; Lamborn KR; Larson DA; Malec MK; McDermott MW; Sneed PK; Wara WM; Wilson CB
J Neurosurg; 1996 Mar; 84(3):442-8. PubMed ID: 8609556
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
Malmström A; Grønberg BH; Marosi C; Stupp R; Frappaz D; Schultz H; Abacioglu U; Tavelin B; Lhermitte B; Hegi ME; Rosell J; Henriksson R;
Lancet Oncol; 2012 Sep; 13(9):916-26. PubMed ID: 22877848
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.
Slotman BJ; Kralendonk JH; van Alphen HA; Kamphorst W; Karim AB
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):895-8. PubMed ID: 8598367
[TBL] [Abstract][Full Text] [Related]
19. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
[TBL] [Abstract][Full Text] [Related]
20. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
